Be aware people with bleeding disorders! a€’ I mean people who have disorders such as hemophilia. You are more vulnerable to risk from emerging infectious agents in plasma and blood transfusions. This is concluded by an international team of scientists, including a hematologist from Thomas Jefferson University in Philadelphia.
So, whats the solution? According to the scientists, recombinant therapies, that is, those produced in the laboratory, must always be an option to handle these situations.
According to journal Lancet, coagulation-factor concentrates (CFC) from the blood plasma are now deemed safe from most known infectious agents, such as hepatitis B and C viruses and HIV. CFC is used for individuals with bleeding disorders. This finding defies what it was two decades ago. But plasma-derived products will continue to challenge with the risk factors remaining.
Via: Science Daily